Ambu A/S (OTCMKTS:AMBBY – Get Free Report) announced a dividend on Tuesday, November 5th, NASDAQ reports. Investors of record on Friday, December 6th will be paid a dividend of 0.0557 per share on Monday, December 23rd. The ex-dividend date of this dividend is Friday, December 6th.
Ambu A/S Trading Down 1.8 %
AMBBY traded down $0.32 during trading hours on Wednesday, reaching $17.12. The company’s stock had a trading volume of 582 shares, compared to its average volume of 711. The stock has a market cap of $4.02 billion and a PE ratio of 71.33. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.52 and a quick ratio of 1.51. Ambu A/S has a fifty-two week low of $12.65 and a fifty-two week high of $22.65. The business’s 50-day moving average is $19.02 and its 200-day moving average is $19.05.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its earnings results on Friday, August 30th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 8.09% and a net margin of 8.55%. The firm had revenue of $199.56 million for the quarter.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
See Also
- Five stocks we like better than Ambu A/S
- How to Invest in Biotech Stocks
- What a Trump Win Looks Like for the Market Now and Into 2025
- Top Biotech Stocks: Exploring Innovation Opportunities
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- How to Buy Cheap Stocks Step by Step
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.